G

GW Research | Chula Vista, CA

Research site
(Unclaimed)
Location
353 Church Avenue, Chula Vista, California, United States of America

Site insights

Top conditions

Top treatments

Relamorelin
Vonoprazan
SPD476
CVC
Lanifibranor
Deudomperidone
HTD1801
CDX-0159
Cenicriviroc
CIN-102

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 19 total trials

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Enrolling
NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: IVA337

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adult Eosinophilic Esophagitis patients.

Enrolling
Eosinophilic Esophagitis
Biological: barzolvolimab
Drug: Matching Placebo

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help reduce the symptoms associated with diabetic gastr...

Enrolling
Diabetic Gastroparesis
Drug: Placebo
Drug: CIN-102 Dose 2

A phase 2b, multicenter, randomized, double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver...

Active, not recruiting
Nonalcoholic Steatohepatitis (NASH)
Type 2 Diabetes
Drug: Placebo
Drug: HTD1801

Trial sponsors

Allergan logo
Exact Sciences Corporation logo
Phathom Pharmaceuticals logo
Bausch Health logo
Celldex Therapeutics logo
C
H
I
M
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems